Strides Pharma Science Completes US
Published on: Dec. 24, 2025, 6:37 p.m. | Source: scanx.trade
Strides Pharma Science successfully completed a routine US-FDA inspection at its Chestnut Ridge, New York formulations facility from December 17-23, 2025. The company received Form 483 with four procedural observations that are not expected to impact commercial product supply, with the subsidiary committed to addressing all findings within the stipulated timeframe.
